Vimy Pharmaceuticals Corp.

Vimy Pharmaceuticals Corp. recorded three purchase transactions totaling 200,700 CAD during the recent period. Director Zachary Goldenberg executed all these acquisitions on September 28, 2026. No sales occurred, reflecting exclusive accumulation activity by this single insider. These movements follow the latest results financiers without additional context regarding market performance or upcoming corporate disclosures.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.3
Goldenberg, Zachary Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
471.94
Quantity 109
Value CA$2,329,443
1.3
Goldenberg, Zachary Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
367.12
Quantity 2,539
Value CA$513,925
1.3
Goldenberg, Zachary Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
161.01
Quantity 28,637
Value CA$3,921,360
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-16 2026-09-28 B Purchase

Director of Issuer

Non-Executive Director
109
471.94
CA$2,329,443
109 471.94 CA$2,329,443
2026-11-16 2026-09-28 B Purchase

Director of Issuer

Non-Executive Director
2,539
367.12
CA$513,925
2,539 367.12 CA$513,925
2026-11-16 2026-09-28 B Purchase

Director of Issuer

Non-Executive Director
28,637
161.01
CA$3,921,360
28,637 161.01 CA$3,921,360
Explore more

More insider trading research around Vimy Pharmaceuticals Corp.